Risks and adverse clinical outcomes of peripheral arterial disease in patients with stable coronary artery disease after percutaneous coronary intervention

Qianyin Huang, Jie Liu, Xusheng Yang, Minghua Lv, Chenzhu Zhang, Zhihong Zeng, Kaixin Huang, Yi Long, Xiaoyan Shi, Joe Zhuo, Elizabeth Zhou, Kaijun Xing, Zhuolun Li, Haoye Qiu, Jintong Pan, H. K. Lee, Shen-heng LiResearch Square 2025 · DOI

Introduction

Atherosclerosis is rarely a localized condition. When arteries narrow in the heart (Coronary Artery Disease, or CAD), they often narrow elsewhere, such as in the lower extremities (Peripheral Arterial Disease, or PAD). While PAD is a known risk factor for long-term mortality, there is limited granular data on how it affects a broader range of clinical outcomes—specifically stroke and myocardial infarction (MI)—in patients already treated for stable CAD via percutaneous coronary intervention (PCI). This study investigates the "prognostic burden" of PAD and identifies patient characteristics that predict its presence.

Methods

This retrospective cohort study analyzed data from 204 consecutive patients with newly diagnosed stable CAD who underwent PCI at Shinonoi General Hospital between 2014 and 2017. To minimize bias and simulate a randomized environment, researchers employed Inverse Probability of Treatment Weighting (IPTW). They assessed four-year outcomes, including all-cause death (ACD), a composite of ACD, non-fatal MI, and stroke (ACD-MI-Stroke), and a composite of cardiac death, non-fatal MI, and stroke (CD-MI-Stroke).

Predictors of Peripheral Arterial Disease

The study identified several independent predictors for the presence of PAD in CAD patients:

  • Diabetes mellitus (DM)
  • Dyslipidemia (DLP)
  • Old cerebral infarction (OCI)
  • Coronary ostial lesions (blockages at the origin of a coronary artery)
  • Elevated triglycerides (TG)

Interestingly, while diabetes was a predictor for the presence of PAD, it did not significantly increase primary endpoint events within this specific cohort, suggesting that modern therapeutic management may be mitigating some traditional risks.

Impact on Clinical Outcomes

The presence of PAD significantly worsened the four-year prognosis for patients following PCI. Key findings include:

  • Triple the Risk: After IPTW adjustment, PAD was associated with an approximately threefold increased risk for the composite endpoint of ACD-MI-Stroke (Hazard Ratio [HR]: 3.0–3.2, $p \le 0.008$).
  • All-Cause Mortality: PAD also tripled the risk of all-cause death specifically (HR ≈ 3.0–3.1, $p \le 0.047$).
  • Incidence Rates: Patients with PAD had a significantly higher incidence of the composite endpoint (24.5% vs. 9.9%) and stroke alone (11.3% vs. 3.3%) compared to those without PAD.

The researchers also noted a "cholesterol paradox": patients who experienced adverse events often had lower median total and LDL cholesterol levels. This may suggest that in severely ill populations, lower cholesterol reflects malnutrition or chronic systemic inflammation rather than cardiovascular health.

Conclusion and Limitations

PAD serves as a potent marker of advanced, systemic atherosclerosis and a major predictor of adverse outcomes in stable CAD patients post-PCI. However, the study's small sample size (n=204) and single-center retrospective design limit its generalizability. Furthermore, the reliance on clinical manifestations to diagnose PAD may have missed subclinical cases. Future research should involve larger, multi-center cohorts and explore genetic profiling to improve early detection and personalized intervention strategies.

Summary updated

Abstract

<title>Abstract</title> Background <bold>​</bold> ​ While peripheral artery disease (PAD) is an established risk factor for long-term mortality in stable coronary artery disease (CAD) patients following percutaneous coronary intervention (PCI), its predictors and impact on a broader range of clinical outcomes require further investigation.​ <bold>​</bold> Methods <bold>​</bold> ​ This study enrolled 204 consecutive patients with newly diagnosed stable CAD undergoing PCI at Shinonoi General Hospital between October 2014 and October 2017. The association between PAD and 4-year outcomes—including all-cause death (ACD), the composite of ACD, non-fatal myocardial infarction (MI), and stroke (ACD-MI-Stroke), the composite of cardiac death (CD), non-fatal MI, and stroke (CD-MI-Stroke), and stroke alone—was assessed using inverse probability of treatment weighting (IPTW) and adjusted Kaplan-Meier curves.​ <bold>​</bold> Results <bold>​</bold> ​ Multivariable analysis identified diabetes mellitus (DM), dyslipidemia (DLP), old cerebral infarction (OCI), coronary ostial lesions, and high triglycerides (TG) as independent predictors of PAD. For the ACD-MI-Stroke endpoint, IPTW analysis demonstrated that PAD was consistently associated with a significant, approximately threefold increased risk (hazard ratio [HR]: 3.0-3.2), with narrow confidence intervals and sustained significance (p ≤ 0.008). Although the association between PAD and ACD was of borderline significance in the unadjusted model (HR: 2.51, 95% confidence interval [CI]: 0.93–6.74), IPTW adjustment revealed a robust and consistently significant threefold risk (HR ≈ 3.0-3.1, <italic>p</italic> ≤ 0.047). For the CD-MI-Stroke endpoint, the statistical precision of the PAD effect was attenuated with the inclusion of more covariates. Moreover, adjusted Kaplan-Meier curves consistently showed a lower survival probability for patients with PAD across all four outcomes over the 4-year follow-up.​ <bold>​</bold> Conclusions <bold>​</bold> ​ In CAD patients undergoing PCI, PAD independently and substantially increases the risk of multiple adverse outcomes, notably ACD, stroke and combinations involving them. DM, DLP, OCI, coronary ostial lesions, and elevated TG levels were identified as significant risk factors for the presence of PAD.
BibTeX
@inproceedings{huang2025risks,
  author = {Qianyin Huang and Jie Liu and Xusheng Yang and Minghua Lv and Chenzhu Zhang and Zhihong Zeng and Kaixin Huang and Yi Long and Xiaoyan Shi and Joe Zhuo and Elizabeth Zhou and Kaijun Xing and Zhuolun Li and Haoye Qiu and Jintong Pan and H. K. Lee and Shen-heng Li},
  title = {{Risks and adverse clinical outcomes of peripheral arterial disease in patients with stable coronary artery disease after percutaneous coronary intervention}},
  booktitle = {Research Square},
  year = {2025},
  doi = {10.21203/rs.3.rs-7836278/v1},
}
Figure